Mereo BioPharma Group plc (MREO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 457.29M |
| Enterprise value | 414.65M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 44.24 |
| Price/book (mrq) | 10.67 |
| Enterprise value/revenue | 41.46 |
| Enterprise value/EBITDA | -1.21 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 169.42% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 4.3600 |
| 52-week low 3 | 0.9200 |
| 50-day moving average 3 | 3.0426 |
| 200-day moving average 3 | 2.4492 |
Share statistics
| Avg vol (3-month) 3 | 1.05M |
| Avg vol (10-day) 3 | 577.65k |
| Shares outstanding 5 | 140.27M |
| Implied shares outstanding 6 | 140.24M |
| Float 8 | 440.01M |
| % held by insiders 1 | 0.54% |
| % held by institutions 1 | 60.02% |
| Shares short (30 Apr 2024) 4 | 2.83M |
| Short ratio (30 Apr 2024) 4 | 3.14 |
| Short % of float (30 Apr 2024) 4 | 2.43% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.02% |
| Shares short (prior month 28 Mar 2024) 4 | 2.33M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -263.41% |
| Operating margin (ttm) | -256.48% |
Management effectiveness
| Return on assets (ttm) | -20.59% |
| Return on equity (ttm) | -46.10% |
Income statement
| Revenue (ttm) | 10M |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -25.04M |
| Net income avi to common (ttm) | -26.34M |
| Diluted EPS (ttm) | -0.1500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 48.66M |
| Total cash per share (mrq) | 0.07 |
| Total debt (mrq) | 6.02M |
| Total debt/equity (mrq) | 14.05% |
| Current ratio (mrq) | 4.86 |
| Book value per share (mrq) | 0.31 |
Cash flow statement
| Operating cash flow (ttm) | -19.88M |
| Levered free cash flow (ttm) | -12.14M |
© 2024 Yahoo. All rights reserved.